skip to main content

H.R. 4800 (116th): Pro-LIFE Act


The text of the bill below is as of Oct 22, 2019 (Introduced). The bill was not enacted into law.


I

116th CONGRESS

1st Session

H. R. 4800

IN THE HOUSE OF REPRESENTATIVES

October 22, 2019

introduced the following bill; which was referred to the Committee on Energy and Commerce

A BILL

To amend title IV of the Public Health Service Act to prohibit sale or transactions relating to human fetal tissue.

1.

Short title

This Act may be cited as the Prohibiting the Life-Ending Industry of Fetal Organ Exchange Act or the Pro-LIFE Act.

2.

Prohibiting sale or transactions relating to human fetal tissue

Section 498B(e) of the Public Health Service Act (42 U.S.C. 298g–2(e)) is amended by striking paragraph (3) and inserting the following new paragraph:

(3)

The term valuable consideration includes—

(A)

any payment made or debt incurred;

(B)

any gift, honorarium, or recognition of value bestowed;

(C)

any price, charge, or fee which is waived, forgiven, reduced, or indefinitely delayed,

(D)

any loan or debt which is canceled or otherwise forgiven;

(E)

the transfer of any item from one person to another or provision of any service or granting of any opportunity for which a charge is customarily made, without charge or for a reduced charge; and

(F)

any payments associated with the transportation, implantation, processing, preservation, quality control, or storage of human fetal tissue.

.